2 completed, 2 recruiting, 1 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Recruiting 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Fasenra: new trials by email Literature Review of Fasenra trials Research Report on Fasenra
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Benralizumab - Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Phase 3 | Recruiting | AstraZeneca | 230 | 2026-07-24 | 2026-11-13 |
| A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases Benralizumab - Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES) | Phase 3 | Recruiting | AstraZeneca | 14 | 2025-04-17 | 2026-10-28 |
| STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma Benralizumab - Severe Eosinophilic Asthma | Phase 3 | Completed | AstraZeneca | 504 | 2024-02-28 | 2026-09-03 |
| Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study) Benralizumab, Placebo - Eosinophilic Gastritis, Eosinophilic Gastroenteritis | Phase 3 | Terminated | AstraZeneca | 12 | 2022-01-18 | 2025-07-14 |
| Benralizumab for Eosinophilic Gastritis (BEGS) Benralizumab, Placebo - Eosinophilic Gastritis or Gastroenteritis | Phase 2 / Phase 3 | Completed | Children's Hospital Medical Center, Cincinnati | 26 | 2018-04-23 | 2022-02-03 |
Churg-Strauss Syndrome (2) · Eosinophilic enteropathy (2) · Gastroenteritis (2) · Asthma (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Hypereosinophilic Syndrome (1) · Intestinal Diseases (1) · Pulmonary Eosinophilia (1) · Stomach Diseases (1)
AstraZeneca (4) · Children's Hospital Medical Center, Cincinnati (1)
United States (4) · Netherlands (3) · Poland (3) · Brazil (2) · Canada (2) · France (2) · India (2) · Israel (2) · Italy (2) · Turkey (Türkiye) (2) · Argentina (1) · Austria (1) · Belgium (1) · China (1) · Japan (1)
HuaHao Shen, Professor (1) · Marc E Rothenberg, MD, PhD (1) · Marc E. Rothenberg, MD, PhD (1) · Min Zhang, Professor (1)
2023 (1)